Literature DB >> 33040253

Radiation-Associated Valvular Disease.

Samantha Xu1, Eoin Donnellan1, Milind Y Desai2,3.   

Abstract

PURPOSE OF REVIEW: Radiation-associated valvular disease (RAVD) is characterized by late valvular manifestations following radiation exposure to the mediastinum. Review of current guidelines was performed to examine best practices to reduce risk and optimize outcomes in this patient population. RECENT
FINDINGS: Early and consistent screening and comprehensive and careful planning are critical in managing RAVD. Due to long latency periods, serial screening and targeted evaluation of risk factors are essential to early detection. Varying and complex presentations of RAVD require an integrated team of experienced specialists equipped with multimodality imaging-based screening protocols to stratify risk, plan intervention, and evaluate treatment response. Patients with valvular manifestations associated with radiation therapy call for an individualized plan of care involving longitudinal multimodality imaging-based screening and experienced decision-making regarding timing and strategy of intervention to improve patient outcomes.

Entities:  

Keywords:  Cancer; Cardio-oncology; Radiation therapy; Radiation-associated cardiac disease; Radiation-associated valvular disease

Mesh:

Year:  2020        PMID: 33040253     DOI: 10.1007/s11886-020-01411-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  1 in total

Review 1.  Chest Pain in the Cancer Patient.

Authors:  Sara Tyebally; Aruni Ghose; Daniel H Chen; Aderonke T Abiodun; Arjun K Ghosh
Journal:  Eur Cardiol       Date:  2022-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.